(Q87355944)
Statements
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission (English)
Norbert Vey
Jean-Henri Bourhis
Nicolas Boissel
Dominique Bordessoule
Aude Charbonnier
Anne Etienne
Pascale Andre
François Romagne
Don Benson
Herve Dombret